Carcinogenesis Advance Access originally published online on February 24, 2005
Carcinogenesis 2005 26(6):1138-1151; doi:10.1093/carcin/bgi046
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis vol.26 no.6 © Oxford University Press 2005; all rights reserved.
A comparison of somatic mutational spectra in healthy study populations from Russia, Sweden and USA
Department of Biosciences, The Karolinska Institute, Novum, SE-14157 Huddinge, Sweden and 1 Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory, L-441, PO Box 808, Livermore, CA 94550, USA
* To whom correspondence should be addressed. Tel: +46 8 6089254; Fax: +46 8 6081501; E-mail: bo.lambert{at}cnt.ki.se
A comparison of mutation spectra at the hypoxanthine–guanine phosphoribosyl transferase (HPRT) gene of peripheral blood T-lymphocytes may provide an insight into the aetiology of somatic mutation contributing to carcinogenesis and other diseases. To increase the knowledge of mutation spectra in healthy people, we have analysed HPRT mutant T-cells of 50 healthy Russians originally recruited as controls in a study involving Chernobyl clean-up workers [I.M.Jones, H.Galick, P.Kato et al. (2002) Radiat. Res., 158, 424–442]. Reverse transcriptase–polymerase chain reactions and DNA sequencing identified 161 independent mutations among 176 thioguanine-resistant mutants. Forty mutations affected splicing mechanisms and 27 deletions or insertions of 1–60 nt were identified. Ninety-four single base substitutions were identified, including 62 different mutations at 55 different nucleotide positions, of which 19 had not been reported previously in human T-cells. Comparison of this base substitution spectrum with mutation spectra in a USA [K.J.Burkhart-Schultz, C.L.Thompson and I.M.Jones (1996) Carcinogenesis, 17, 1871–1883] and two Swedish populations [A.Podlutsky, A.-M.Österholm, S.-M.Hou, A.Hofmaier and B.Lambert (1998) Carcinogenesis, 19, 557–566; A.Podlutsky, S.M.Hou, F.Nyberg, G.Pershagen and B.Lambert (1999) Mutat. Res., 431, 325–39] revealed similarity in the type, frequency and distribution of mutations in the four spectra, consistent with aetiologies inherent in human metabolism. There were 15–19 identical mutations in the three pairwise comparisons of Russian with USA and Swedish spectra. Intriguingly, there were 21 mutations unique to the Russian spectrum, and comparison by the Monte Carlo method of W.T.Adams and T.R.Skopek [(1987) J. Mol. Biol., 194, 391–396] indicated that the Russian spectrum was different from both Swedish spectra (P = 0.007, 0.002), but not different from the USA spectrum (P = 0.07) when Bonferroni correction for multiple comparisons was made (P < 0.008 required for significance). Age and smoking did not account for these differences. Other factors causing mutational differences need to be explored.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H Kehrer-Sawatzki and D N Cooper Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes? J. Med. Genet., October 1, 2008; 45(10): 622 - 631. [Abstract] [Full Text] [PDF]
|
|